ArticleJournal of pediatric psychology2016
Psychometric Properties of the Psychosocial Assessment Tool-General in Adolescents and Young Adults With Sickle Cell Disease.
Article in Journal of pediatric psychology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02851615 (SCThrive), which is not on this map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
SCThrive: Improving Self-Management in Adolescents With Sickle Cell Disease
Who cites it
10 citing papers in PubMed.
- Assessing psychosocial risk factors in children with Sickle Cell Disease.BMC health services research · 2025Article
- Impact of Neighborhood Disadvantage on Preventive and Acute Care Utilization in Sickle Cell Disease.Pediatric blood & cancer · 2025Article
- Identifying Chronic Pain Subgroups in Pediatric Sickle Cell Disease: A Cluster-Analytic Approach.The Clinical journal of pain · 2022Article
- Psychosocial risk and health care utilization in pediatric sickle cell disease.Pediatric blood & cancer · 2021Article
- Sociodemographic factors and health-related, neuropsychological, and psychosocial functioning in youth with spina bifida.Rehabilitation psychology · 2021Article
- Psychosocial Screening in Sickle Cell Disease: Validation of the Psychosocial Assessment Tool.Journal of pediatric psychology · 2020Article
- Observational
- Pilot of the Chronic Disease Self-Management Program for Adolescents and Young Adults With Sickle Cell Disease.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2017Article
- Introduction to the Special Issue on Diversity and Health Disparities: Where Have We Been and Where Are We Going?Journal of pediatric psychology · 2016Article
- Comprehensive neuropsychological evaluation of children and adolescents with sickle cell anemia: a hospital-based sample.Revista brasileira de hematologia e hemoterapiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesAdolescents and young adults (AYAs) with sickle cell disease (SCD) experience psychosocial factors that increase their risk for poor disease management and health outcomes. Routine assessment of psychosocial factors that perpetuate health disparities is recommended. The Psychosocial Assessment Tool 2.0_General (PAT2.0_GEN) AYA is a psychosocial screener with potential clinical utility in AYAs with SCD. This article is a preliminary examination of the internal consistency and predictive validity of this measure in a sample of 45 AYAs with SCD.
methodsParticipants completed the PAT2.0_GEN AYA, Pediatric Quality of Life Inventory, and a demographics form; psychosocial referral data were also collected.
resultsInternal consistency for the PAT2.0_GEN AYA was acceptable except for the Family Beliefs (0.67) and Structure and Resources subscales (0.37). PAT2.0_GEN AYA scores were associated with an increased likelihood of referral for intervention within 4 months.
conclusionsThe PAT2.0_GEN AYA holds promise as a screener to identify psychosocial risk factors that may compromise health outcomes in AYAs with SCD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.